Home › Shire says FDA declines to approve eye drug Lifitegrast
 

Keywords :   


Shire says FDA declines to approve eye drug Lifitegrast

2015-10-17 08:11:06| Biotech - Topix.net

The U.S. Food and Drug Administration notified Shire Plc it will not approve its eye drug Lifitegrast, the company said on Friday, adding that the U.S. health regulator recommended the company conduct additional clinical studies. The news comes over a week before the FDA was supposed to make a decision on Lifitegrast on Oct 25. Shire said it received a complete response letter, which the FDA sends to let a drug developer know a marketing application will not be approved in its present form.

Tags: eye drug approve fda

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
20.05China hits back at US and EU as trade rows deepen
20.05How should countries deal with falling birth rates?
20.05Eastern North Pacific Tropical Weather Outlook
20.05Atlantic Tropical Weather Outlook
20.05Water investors have withdrawn billions, says research
19.05Atlantic Tropical Weather Outlook
19.05Eastern North Pacific Tropical Weather Outlook
19.05IT Cosmetics and Kenvue Launch New Products
More »